within Pharmacolibrary.Drugs.ATC.V;

model V09HA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 2.0,
    adminDuration  = 600,
    adminMass      = 0.74,
    adminCount     = 1,
    Vd             = 0.004200000000000001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Technetium (99mTc) antigranulocyte antibody is a radiolabeled monoclonal antibody preparation used as a diagnostic agent for imaging sites of infection or inflammation, such as osteomyelitis, by binding to granulocytes. It is not broadly used today and is replaced in many regions by other radiopharmaceuticals, but remains approved for some niche diagnostic uses.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are generally referenced for healthy adult subjects undergoing diagnostic procedures. Published pharmacokinetic data specific to technetium (99mTc) antigranulocyte antibody are scarce, and most available data come from small clinical studies or product monographs.</p><h4>References</h4><ol><li>S Gratz, T Behr, A Herrmann, K Dresing, L Tarditi, R Franceschini, B Rhodes, K M St√ºrmer, W Becker,Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc-HMPAO labelled white blood cells for the imaging of infection.,European journal of nuclear medicine,1998<a href='https://pubmed.ncbi.nlm.nih.gov/9553168/'>https://pubmed.ncbi.nlm.nih.gov/9553168/</a></li><li>M Sarwar, T Higuchi, K Tomiyoshi, T Inoue, N Oriuchi, A Kbalil, S Alyafei, H Sakahara, J K Chung, K Endo,99mTc-labeled chimeric anti-NCA 95 antigranulocyte monoclonal antibody for bone marrow imaging.,Radiation medicine,1998<a href='https://pubmed.ncbi.nlm.nih.gov/9862166/'>https://pubmed.ncbi.nlm.nih.gov/9862166/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V09HA03;
